Now lets see what happens. I do not think that RS are ever a good thing for investers. The science here is good, and the original plan should stay in place.
well they are not selling enough to break even. looks like more dilution in the future.
they were part of this since 3/3/2010, odd that they did not include JRTI in the news release
anyone having trouble loging on?
Don't let them do it. not at that ratio, that is insane! Years away from comercializing they need to just partner up and I could live with a 1 for 5
would have been nice to have this info before the confrence call. I hope that she gets well too. I lost my mother to this hidiouis desease 5 years past.
Well the cancer came back, wonder what dose she got.
can anyone tell me what is up with the share structure and if they did a 1 for 500 split why is this sub penny
this is a baby bio, the money will come with fda approval or licencing or partnership deal. This stuff works , if it was on a TV comercial it would not have the long list of side effects disclaimer like some of the other #$%$ the fda has approved. Just hold on for the ride
Sentiment: Hold